Georg Hess
10PUBLICATIONS
62CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (10)
Sort by Publication Date:
|Mar 06, 2026
Patient characteristics and treatment outcomes in marginal zone lymphoma: results of the prospective German MZL registry.Alexander Grunenberg, Birgit Schmelzle, Jacqueline Gökeler
|Jan 16, 2026
Results of brexucabtagene-autoleucel for patients with relapsed/refractory Mantle Cell Lymphoma in the routine setting in Germany and Switzerland.Linda Simon, Vladan Vucinic, Kai Rejeski
|Sep 18, 2023
Phase 3 SELENE study: ibrutinib plus BR/R-CHOP in previously treated patients with follicular or marginal zone lymphoma.Loretta J Nastoupil, Georg Hess, Miguel A Pavlovsky
|Oct 18, 2022
Real-world experience among patients with relapsed/refractory mantle cell lymphoma after Bruton tyrosine kinase inhibitor failure in Europe: The SCHOLAR-2 retrospective chart review study.Georg Hess, Martin Dreyling, Lucie Oberic
|May 25, 2022
Cost-effectiveness analysis of KTE-X19 CAR T therapy versus real-world standard of care in patients with relapsed/refractory mantle cell lymphoma post BTKi in England.Svenja Petersohn, Gilles Salles, Michael Wang
|May 13, 2022
Long-term efficacy, safety and neurotolerability of MATRix regimen followed by autologous transplant in primary CNS lymphoma: 7-year results of the IELSG32 randomized trial.Andrés J M Ferreri, Kate Cwynarski, Elisa Pulczynski
Pageof 2
Frequent Collaborators
2 joint publications
Pier Luigi Zinzani
2 joint publications
Gilles Salles
1 joint publications
Igor Aurer
1 joint publications
Mats Jerkeman
1 joint publications
Steven Le Gouill
1 joint publications
Vincent Ribrag
1 joint publications
Marek Trněný
1 joint publications
Carlo Visco
1 joint publications
Francesco Zaja
1 joint publications
Martin Schreder
